Document is current
Any future updates will be listed below
-
Authors
Huda, Tanvir M. https://orcid.org/0000-0002-8996-4361
Rahman, Mohammad Masudur
Raihana, Shahreen
Islam, Sajia
Tahsina, Tazeen
Alam, Ashraful
Agho, Kingsley
Rasheed, Sabrina
Hayes, Alison
Karim, Mohd Anisul
Rahman, Qazi Sadequr
Siddique, Abu Bakkar
Moinuddin, Md
Chowdhury, Morseda
Ghose, Lucky
Afsana, Kaosar
Raynes-Greenow, Camille
El Arifeen, Shams
Dibley, Michael J.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1026864)
- License Information
-
More Information
Article History
Received: 15 January 2018
Accepted: 14 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The Ethical Review Committee (ERC) of the icddr,b, and the Human Research Ethics Committee (HREC) of University of Sydney have granted ethics approval for this study. Any amendment to the protocol will be communicated to both the ERC. We obtained written informed consent, from pregnant women during enrolment into the study, which provided full disclosure regarding the study. We will strictly maintain the privacy, anonymity and confidentiality of the information provided by respondents during all phases of the trial. All information will be stored in an encrypted database with participant’s study ID instead of personal identifiers, and none but the associated investigators and data management team will have access to collected data.
: Not applicable.
: The authors declare that they do not have any competing interest. Eskayef, the manufacturer of iron-folic acid supplements used in the study, has no involvement in the study conception, design, implementation, collection and interpretation of data.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
